CDK4 and glioblastoma: Subsequently, in Fig. 1B, we validated these findings by examining data from an open-source database (The Cancer Genome Atlas Program, TCGA), which also revealed high expression levels of CDK4 and CDK6 in GBM (glioblastoma).